Immunogenicity and safety of Ad26.RSV.preF/RSV preF protein vaccine at predicted intermediate- and end-of-shelf-life as an evaluation of potency throughout shelf life
Hosman, Tessa ; van Heesbeen, Roy ; Bastian, Arangassery Rosemary ; Hu, Weihong ; Comeaux, Christy ; Ligtenberg, Nynke ; van Montfort, Bart ; Callendret, Benoît ; Heijnen, Esther
Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2344970-2344970 [Periódico revisado por pares]United States: Taylor & Francis
Texto completo disponível
Anterior
Página Inicial
RSS
Feed
Políticas
Fale Conosco-
Realização:
Logos de Redes Sociais: 